SCHEMBL2490939

SCHEMBL2490939

CC(C)(NC(=O)CC1CCCC1)C(=O)Nc1nc(-c2ccc(F)cc2)c(Oc2ccc(F)cc2)s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 5/20 0.41
ACHE P22303 3/20 0.40
MAPT P10636 1/20 0.40
ALDH1A1 P00352 2/20 0.39
PKM P14618 1/20 0.39
PI4KB Q9UBF8 1/20 0.39
CSNK1D P48730 1/20 0.38
ROCK2 O75116 1/20 0.38
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
KMT2A Q03164 1/20 0.37
PTGDR2 Q9Y5Y4 1/20 0.37
HTT P42858 1/20 0.36
POLB P06746 1/20 0.36
KCNQ3 O43525 1/20 0.36
KCNQ2 O43526 1/20 0.36
EPHX2 P34913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2485003 0.96 RORC (0.42) RORCACHEMAPTALDH1A1PKM
SCHEMBL2318514 0.85 RORC (0.45) RORCACHEMAPTALDH1A1PKM
SCHEMBL2485723 0.85 ACHE (0.45) RORCACHEMAPTALDH1A1PKM
SCHEMBL2485715 0.84 MEN1 (0.44) RORCACHEALDH1A1PKMKDM4E
SCHEMBL2487593 0.83 ALDH1A1 (0.46) RORCACHEMAPTALDH1A1PKM
SCHEMBL2314979 0.83 ALDH1A1 (0.41) RORCACHEMAPTALDH1A1PKM
SCHEMBL2488112 0.83 RORC (0.41) RORCACHEMAPTALDH1A1PKM
SCHEMBL2484976 0.82 ALDH1A1 (0.45) RORCACHEMAPTALDH1A1PKM
SCHEMBL2321338 0.82 ACHE (0.39) RORCACHEMAPTALDH1A1PKM
SCHEMBL2490686 0.81 SMN1; SMN2 (0.45) RORCMAPTALDH1A1PKMROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2559455-A1 Heteroaryl derivatives as DGAT1 inhibitors Novartis AG (CH) 2013-02-20 EP disclosed
EP-2548618-A2 Organic compounds Novartis AG (CH) 2013-01-23 EP disclosed
EP-2380631-A1 Heteroaryl derivatives as DGAT1 inhibitors Novartis AG (CH) 2011-10-26 EP disclosed